Skip to Content Skip to Content

Health Sciences

Reset All Filters
2005 Results
Penn Researchers Use New Imaging to Show Key Enzyme in Ovarian Cancer

Penn Researchers Use New Imaging to Show Key Enzyme in Ovarian Cancer

A new imaging test may provide the ability to identify ovarian cancer patients who are candidates for an emerging treatment that targets a key enzyme cancer cells need to survive. Currently, epithelial ovarian cancer patients with BRCA1 mutations are considered candidates for the treatment, but there is no method to measure the enzyme levels to help guide treatment choices.

John Infanti

Two Penn Physicians Awarded SU2C Immuno-Oncology Innovative Research Grants

Two Penn Physicians Awarded SU2C Immuno-Oncology Innovative Research Grants

Two doctors in the Perelman School of Medicine at the University of Pennsylvania have been awarded Immuno-Oncology Innovative Research Grants (IRG) by Stand Up to Cancer (SU2C). Michael Farwell, MD, an assistant professor of Radiology, and Gregory L. Beatty, MD, PhD, an assistant professor of Hematology Oncology, and are two of just 10 researchers to receive these grants.

John Infanti

Link between Common Prostate Cancer Treatment, Dementia Detailed in New Penn Study

Link between Common Prostate Cancer Treatment, Dementia Detailed in New Penn Study

A new analysis of patients who have undergone treatment for prostate cancer shows a connection between androgen deprivation therapy (ADT) – a testosterone-lowering therapy and a common treatment for the disease – and dementia, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.

John Infanti

Penn Studies Find Promise for Innovations in Liquid Biopsies

Penn Studies Find Promise for Innovations in Liquid Biopsies

From using fluid in the lungs to better understand the potential of immunotherapy treatments in lung cancer, to tracking circulating tumor cells in prostate cancer, to conducting RNA sequencing of cancer cell clusters from the blood of pancreatic cancer patients, to finding new ways to biopsy tissue from patients who may have esophageal cancer, a series of studies from the Perelman School

John Infanti